<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    111, Inc.

    verified_userVerify Profile
    Companies » Consumer Services » Food & Drug Retailers » Drug Retailers

    About 111, Inc.

    111,Inc., co-founded by Gang Yu and Junling Liu in 2010, is a leading digital and mobile healthcare platform in China. By applying advanced Internet and information technology, 111,Inc. is devoted to online medical services and online pharmacy through optimized supply chain and cloud services, to increase the efficiency and transparency of drug retail and distribution. 111,Inc. aims to deliver the best and comprehensive healthcare solutions to Chinese people. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $2,300,000,000
    • SIC CODE
      5912
    • NIN CODE
      ####
    • LEADERSHIP
      Dr. Gang Yu and Junling Liu
    • FOUNDED
      2010
    • EMPLOYEES
      1001-5000
    • SECTOR
      Food & Drug Retailers
    • SUBSECTOR
      Drug Retailers

    Company Tags

    No articles found.

    Halozyme Therapeutics, Inc.

    Halozyme Therapeutics, Inc.

    Halozyme is a clinical-stage biotechnology company focused on developing and comme...

    Halozyme is a clinical-stage biotechnology comp...

    Filing Type:    PU
    Concert Pharmaceuticals, Inc.

    Concert Pharmaceuticals, Inc.

    Concert Pharmaceuticals is a clinical stage biopharmaceutical company focused on a...

    Concert Pharmaceuticals is a clinical stage bio...

    Filing Type:    PU
    Anthera Pharmaceuticals, Inc.

    Anthera Pharmaceuticals, Inc.

    Anthera Pharmaceuticals, Inc., a development stage biopharmaceutical company, focu...

    Anthera Pharmaceuticals, Inc., a development st...

    Amount Raised:    $65,500,000
    Fundraising Status:    VT
    Filing Type:    PU
    China Jo-Jo Drugstores, Inc.

    China Jo-Jo Drugstores, Inc.

    Incorporated in 2006 with headquarters in Hangzhou, China, China Jo-Jo Drugstores,...

    Incorporated in 2006 with headquarters in Hangz...

    Filing Type:    PU
    Fred's, Inc.

    Fred's, Inc.

    Tracing our history back to an original store in Coldwater, Mississippi in 1947, F...

    Tracing our history back to an original store i...

    Filing Type:    PU
    NowRx, Inc.

    NowRx, Inc.

    NowRx provides a trusted, reliable way to have your prescriptions delivered, from ...

    NowRx provides a trusted, reliable way to have ...

    Amount Raised:    $2,233,127.00
    Fundraising Status:    EC
    Filing Type:    RACF
    Digimarc Corporation

    Digimarc Corporation

    Digimarc Corp. (NASDAQ: DMRC), based in Beaverton, Oregon, is inventor of the Digi...

    Digimarc Corp. (NASDAQ: DMRC), based in Beavert...

    Filing Type:    PU
    Taoping Inc.

    Taoping Inc.

    Taoping Inc. (formerly known as China Information Technology, Inc.) (TAOP), is a l...

    Taoping Inc. (formerly known as China Informati...

    Filing Type:    PU
    Vivendi SA

    Vivendi SA

    Since 2014, Vivendi has been focused on building a world-class content, media and ...

    Since 2014, Vivendi has been focused on buildin...

    Filing Type:    PU
    Sundial Growers Inc.

    Sundial Growers Inc.

    There are many reasons people choose cannabis - it's used for medicine, for person...

    There are many reasons people choose cannabis -...

    Filing Type:    PU
    Tilray, Inc.

    Tilray, Inc.

    Tilray is a global pioneer in the research, cultivation, production and distributi...

    Tilray is a global pioneer in the research, cul...

    Filing Type:    PU
    Oracle Health, Inc.

    Oracle Health, Inc.

    Oracle Health is developing a Digital Health Insertable (Under The Skin) Cardiac D...

    Oracle Health is developing a Digital Health In...

    Amount Raised:    $182,002.00
    Fundraising Status:    EC
    Filing Type:    CF
    ©2026 National Investor Network. All Rights Reserved.